Veterinary Vaccines Market Size, Share, Price, Trend and Forecast 2022 to 2028

Market Analysis and Insights: Global Veterinary Vaccines Market

The global Veterinary Vaccines market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Veterinary Vaccines market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Veterinary Vaccines market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Veterinary Vaccines market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Veterinary Vaccines market.

Global Veterinary Vaccines Scope and Market Size

Veterinary Vaccines market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Veterinary Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2030.
Segment by Type
Inactivated Vaccines
Live Attenuated Vaccines
Conjugate Vaccines
Toxoid Vaccines
Recombinant Vaccines
DNA Vaccines
Others
Segment by Application
Veterinary Clinic
Veterinary Hospital
Veterinary Research Institute
Retail Pharmacy
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Elanco
Merck
Merial
Zoetis
Advaxis
AmpliPhi Biosciences
Aratana Therapeutics
ARKO Labs
Bayer
CanFel Therapeutics
Ceva Animal Health
Colorado Serum
Epitopix
Genus
Hygieia Biological Laboratories
ImmuCell
Nexvet
Nuovo Biologics
UBI
Valneva
Vetoquinol
Virbac

The information for each competitor/Company Profile includes:

Company Overview
Business Strategy
Key Product Offerings
Financial Performance
Key Performance Indicators
Risk Analysis
Recent Development
Regional Presence
SWOT Analysis

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Veterinary Vaccines product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Veterinary Vaccines, with price, sales, revenue, and global market share of Veterinary Vaccines from 2019 to 2022.

Chapter 3, the Veterinary Vaccines competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Veterinary Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Veterinary Vaccines market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Veterinary Vaccines.

Chapter 13, 14, and 15, to describe Veterinary Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

Estimates 2022-2027 2021-2025 Veterinary Vaccines Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
Market dynamics scenario, along with growth opportunities of the market in the years to come
Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Veterinary Vaccines Market Size Growth Rate by Type: 2018 VS 2022 VS 2030
1.2.2 Inactivated Vaccines
1.2.3 Live Attenuated Vaccines
1.2.4 Conjugate Vaccines
1.2.5 Toxoid Vaccines
1.2.6 Recombinant Vaccines
1.2.7 DNA Vaccines
1.2.8 Others
1.3 Market by Application
1.3.1 Global Veterinary Vaccines Market Share by Application: 2018 VS 2022 VS 2030
1.3.2 Veterinary Clinic
1.3.3 Veterinary Hospital
1.3.4 Veterinary Research Institute
1.3.5 Retail Pharmacy
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Veterinary Vaccines Market Perspective (2018-2030)
2.2 Veterinary Vaccines Growth Trends by Region
2.2.1 Veterinary Vaccines Market Size by Region: 2018 VS 2022 VS 2030
2.2.2 Veterinary Vaccines Historic Market Size by Region (2018-2023)
2.2.3 Veterinary Vaccines Forecasted Market Size by Region (2023-2030)
2.3 Veterinary Vaccines Market Dynamics
2.3.1 Veterinary Vaccines Industry Trends
2.3.2 Veterinary Vaccines Market Drivers
2.3.3 Veterinary Vaccines Market Challenges
2.3.4 Veterinary Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Veterinary Vaccines Players by Revenue
3.1.1 Global Top Veterinary Vaccines Players by Revenue (2018-2023)
3.1.2 Global Veterinary Vaccines Revenue Market Share by Players (2018-2023)
3.2 Global Veterinary Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Veterinary Vaccines Revenue
3.4 Global Veterinary Vaccines Market Concentration Ratio
3.4.1 Global Veterinary Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Veterinary Vaccines Revenue in 2022
3.5 Veterinary Vaccines Key Players Head office and Area Served
3.6 Key Players Veterinary Vaccines Product Solution and Service
3.7 Date of Enter into Veterinary Vaccines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Veterinary Vaccines Breakdown Data by Type
4.1 Global Veterinary Vaccines Historic Market Size by Type (2018-2023)
4.2 Global Veterinary Vaccines Forecasted Market Size by Type (2023-2030)
5 Veterinary Vaccines Breakdown Data by Application
5.1 Global Veterinary Vaccines Historic Market Size by Application (2018-2023)
5.2 Global Veterinary Vaccines Forecasted Market Size by Application (2023-2030)
6 North America
6.1 North America Veterinary Vaccines Market Size (2018-2030)
6.2 North America Veterinary Vaccines Market Size by Country (2018-2023)
6.3 North America Veterinary Vaccines Market Size by Country (2023-2030)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Veterinary Vaccines Market Size (2018-2030)
7.2 Europe Veterinary Vaccines Market Size by Country (2018-2023)
7.3 Europe Veterinary Vaccines Market Size by Country (2023-2030)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Veterinary Vaccines Market Size (2018-2030)
8.2 Asia-Pacific Veterinary Vaccines Market Size by Country (2018-2023)
8.3 Asia-Pacific Veterinary Vaccines Market Size by Country (2023-2030)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Veterinary Vaccines Market Size (2018-2030)
9.2 Latin America Veterinary Vaccines Market Size by Country (2018-2023)
9.3 Latin America Veterinary Vaccines Market Size by Country (2023-2030)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Veterinary Vaccines Market Size (2018-2030)
10.2 Middle East & Africa Veterinary Vaccines Market Size by Country (2018-2023)
10.3 Middle East & Africa Veterinary Vaccines Market Size by Country (2023-2030)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Elanco
11.1.1 Elanco Company Detail
11.1.2 Elanco Business Overview
11.1.3 Elanco Veterinary Vaccines Introduction
11.1.4 Elanco Revenue in Veterinary Vaccines Business (2018-2023)
11.1.5 Elanco Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Veterinary Vaccines Introduction
11.2.4 Merck Revenue in Veterinary Vaccines Business (2018-2023)
11.2.5 Merck Recent Development
11.3 Merial
11.3.1 Merial Company Detail
11.3.2 Merial Business Overview
11.3.3 Merial Veterinary Vaccines Introduction
11.3.4 Merial Revenue in Veterinary Vaccines Business (2018-2023)
11.3.5 Merial Recent Development
11.4 Zoetis
11.4.1 Zoetis Company Detail
11.4.2 Zoetis Business Overview
11.4.3 Zoetis Veterinary Vaccines Introduction
11.4.4 Zoetis Revenue in Veterinary Vaccines Business (2018-2023)
11.4.5 Zoetis Recent Development
11.5 Advaxis
11.5.1 Advaxis Company Detail
11.5.2 Advaxis Business Overview
11.5.3 Advaxis Veterinary Vaccines Introduction
11.5.4 Advaxis Revenue in Veterinary Vaccines Business (2018-2023)
11.5.5 Advaxis Recent Development
11.6 AmpliPhi Biosciences
11.6.1 AmpliPhi Biosciences Company Detail
11.6.2 AmpliPhi Biosciences Business Overview
11.6.3 AmpliPhi Biosciences Veterinary Vaccines Introduction
11.6.4 AmpliPhi Biosciences Revenue in Veterinary Vaccines Business (2018-2023)
11.6.5 AmpliPhi Biosciences Recent Development
11.7 Aratana Therapeutics
11.7.1 Aratana Therapeutics Company Detail
11.7.2 Aratana Therapeutics Business Overview
11.7.3 Aratana Therapeutics Veterinary Vaccines Introduction
11.7.4 Aratana Therapeutics Revenue in Veterinary Vaccines Business (2018-2023)
11.7.5 Aratana Therapeutics Recent Development
11.8 ARKO Labs
11.8.1 ARKO Labs Company Detail
11.8.2 ARKO Labs Business Overview
11.8.3 ARKO Labs Veterinary Vaccines Introduction
11.8.4 ARKO Labs Revenue in Veterinary Vaccines Business (2018-2023)
11.8.5 ARKO Labs Recent Development
11.9 Bayer
11.9.1 Bayer Company Detail
11.9.2 Bayer Business Overview
11.9.3 Bayer Veterinary Vaccines Introduction
11.9.4 Bayer Revenue in Veterinary Vaccines Business (2018-2023)
11.9.5 Bayer Recent Development
11.10 CanFel Therapeutics
11.10.1 CanFel Therapeutics Company Detail
11.10.2 CanFel Therapeutics Business Overview
11.10.3 CanFel Therapeutics Veterinary Vaccines Introduction
11.10.4 CanFel Therapeutics Revenue in Veterinary Vaccines Business (2018-2023)
11.10.5 CanFel Therapeutics Recent Development
11.11 Ceva Animal Health
11.11.1 Ceva Animal Health Company Detail
11.11.2 Ceva Animal Health Business Overview
11.11.3 Ceva Animal Health Veterinary Vaccines Introduction
11.11.4 Ceva Animal Health Revenue in Veterinary Vaccines Business (2018-2023)
11.11.5 Ceva Animal Health Recent Development
11.12 Colorado Serum
11.12.1 Colorado Serum Company Detail
11.12.2 Colorado Serum Business Overview
11.12.3 Colorado Serum Veterinary Vaccines Introduction
11.12.4 Colorado Serum Revenue in Veterinary Vaccines Business (2018-2023)
11.12.5 Colorado Serum Recent Development
11.13 Epitopix
11.13.1 Epitopix Company Detail
11.13.2 Epitopix Business Overview
11.13.3 Epitopix Veterinary Vaccines Introduction
11.13.4 Epitopix Revenue in Veterinary Vaccines Business (2018-2023)
11.13.5 Epitopix Recent Development
11.14 Genus
11.14.1 Genus Company Detail
11.14.2 Genus Business Overview
11.14.3 Genus Veterinary Vaccines Introduction
11.14.4 Genus Revenue in Veterinary Vaccines Business (2018-2023)
11.14.5 Genus Recent Development
11.15 Hygieia Biological Laboratories
11.15.1 Hygieia Biological Laboratories Company Detail
11.15.2 Hygieia Biological Laboratories Business Overview
11.15.3 Hygieia Biological Laboratories Veterinary Vaccines Introduction
11.15.4 Hygieia Biological Laboratories Revenue in Veterinary Vaccines Business (2018-2023)
11.15.5 Hygieia Biological Laboratories Recent Development
11.16 ImmuCell
11.16.1 ImmuCell Company Detail
11.16.2 ImmuCell Business Overview
11.16.3 ImmuCell Veterinary Vaccines Introduction
11.16.4 ImmuCell Revenue in Veterinary Vaccines Business (2018-2023)
11.16.5 ImmuCell Recent Development
11.17 Nexvet
11.17.1 Nexvet Company Detail
11.17.2 Nexvet Business Overview
11.17.3 Nexvet Veterinary Vaccines Introduction
11.17.4 Nexvet Revenue in Veterinary Vaccines Business (2018-2023)
11.17.5 Nexvet Recent Development
11.18 Nuovo Biologics
11.18.1 Nuovo Biologics Company Detail
11.18.2 Nuovo Biologics Business Overview
11.18.3 Nuovo Biologics Veterinary Vaccines Introduction
11.18.4 Nuovo Biologics Revenue in Veterinary Vaccines Business (2018-2023)
11.18.5 Nuovo Biologics Recent Development
11.19 UBI
11.19.1 UBI Company Detail
11.19.2 UBI Business Overview
11.19.3 UBI Veterinary Vaccines Introduction
11.19.4 UBI Revenue in Veterinary Vaccines Business (2018-2023)
11.19.5 UBI Recent Development
11.20 Valneva
11.20.1 Valneva Company Detail
11.20.2 Valneva Business Overview
11.20.3 Valneva Veterinary Vaccines Introduction
11.20.4 Valneva Revenue in Veterinary Vaccines Business (2018-2023)
11.20.5 Valneva Recent Development
11.21 Vetoquinol
11.21.1 Vetoquinol Company Detail
11.21.2 Vetoquinol Business Overview
11.21.3 Vetoquinol Veterinary Vaccines Introduction
11.21.4 Vetoquinol Revenue in Veterinary Vaccines Business (2018-2023)
11.21.5 Vetoquinol Recent Development
11.22 Virbac
11.22.1 Virbac Company Detail
11.22.2 Virbac Business Overview
11.22.3 Virbac Veterinary Vaccines Introduction
11.22.4 Virbac Revenue in Veterinary Vaccines Business (2018-2023)
11.22.5 Virbac Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Veterinary Vaccines Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2030
Table 2. Key Players of Inactivated Vaccines
Table 3. Key Players of Live Attenuated Vaccines
Table 4. Key Players of Conjugate Vaccines
Table 5. Key Players of Toxoid Vaccines
Table 6. Key Players of Recombinant Vaccines
Table 7. Key Players of DNA Vaccines
Table 8. Key Players of Others
Table 9. Global Veterinary Vaccines Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2030
Table 10. Global Veterinary Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2030
Table 11. Global Veterinary Vaccines Market Size by Region (2018-2023) & (US$ Million)
Table 12. Global Veterinary Vaccines Market Share by Region (2018-2023)
Table 13. Global Veterinary Vaccines Forecasted Market Size by Region (2023-2030) & (US$ Million)
Table 14. Global Veterinary Vaccines Market Share by Region (2023-2030)
Table 15. Veterinary Vaccines Market Trends
Table 16. Veterinary Vaccines Market Drivers
Table 17. Veterinary Vaccines Market Challenges
Table 18. Veterinary Vaccines Market Restraints
Table 19. Global Veterinary Vaccines Revenue by Players (2018-2023) & (US$ Million)
Table 20. Global Veterinary Vaccines Market Share by Players (2018-2023)
Table 21. Global Top Veterinary Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Vaccines as of 2022)
Table 22. Ranking of Global Top Veterinary Vaccines Companies by Revenue (US$ Million) in 2022
Table 23. Global 5 Largest Players Market Share by Veterinary Vaccines Revenue (CR5 and HHI) & (2018-2023)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Veterinary Vaccines Product Solution and Service
Table 26. Date of Enter into Veterinary Vaccines Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Veterinary Vaccines Market Size by Type (2018-2023) & (US$ Million)
Table 29. Global Veterinary Vaccines Revenue Market Share by Type (2018-2023)
Table 30. Global Veterinary Vaccines Forecasted Market Size by Type (2023-2030) & (US$ Million)
Table 31. Global Veterinary Vaccines Revenue Market Share by Type (2023-2030)
Table 32. Global Veterinary Vaccines Market Size by Application (2018-2023) & (US$ Million)
Table 33. Global Veterinary Vaccines Revenue Market Share by Application (2018-2023)
Table 34. Global Veterinary Vaccines Forecasted Market Size by Application (2023-2030) & (US$ Million)
Table 35. Global Veterinary Vaccines Revenue Market Share by Application (2023-2030)
Table 36. North America Veterinary Vaccines Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Veterinary Vaccines Market Size by Country (2023-2030) & (US$ Million)
Table 38. Europe Veterinary Vaccines Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Veterinary Vaccines Market Size by Country (2023-2030) & (US$ Million)
Table 40. Asia-Pacific Veterinary Vaccines Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Veterinary Vaccines Market Size by Region (2023-2030) & (US$ Million)
Table 42. Latin America Veterinary Vaccines Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Veterinary Vaccines Market Size by Country (2023-2030) & (US$ Million)
Table 44. Middle East & Africa Veterinary Vaccines Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Veterinary Vaccines Market Size by Country (2023-2030) & (US$ Million)
Table 46. Elanco Company Detail
Table 47. Elanco Business Overview
Table 48. Elanco Veterinary Vaccines Product
Table 49. Elanco Revenue in Veterinary Vaccines Business (2018-2023) & (US$ Million)
Table 50. Elanco Recent Development
Table 51. Merck Company Detail
Table 52. Merck Business Overview
Table 53. Merck Veterinary Vaccines Product
Table 54. Merck Revenue in Veterinary Vaccines Business (2018-2023) & (US$ Million)
Table 55. Merck Recent Development
Table 56. Merial Company Detail
Table 57. Merial Business Overview
Table 58. Merial Veterinary Vaccines Product
Table 59. Merial Revenue in Veterinary Vaccines Business (2018-2023) & (US$ Million)
Table 60. Merial Recent Development
Table 61. Zoetis Company Detail
Table 62. Zoetis Business Overview
Table 63. Zoetis Veterinary Vaccines Product
Table 64. Zoetis Revenue in Veterinary Vaccines Business (2018-2023) & (US$ Million)
Table 65. Zoetis Recent Development
Table 66. Advaxis Company Detail
Table 67. Advaxis Business Overview
Table 68. Advaxis Veterinary Vaccines Product
Table 69. Advaxis Revenue in Veterinary Vaccines Business (2018-2023) & (US$ Million)
Table 70. Advaxis Recent Development
Table 71. AmpliPhi Biosciences Company Detail
Table 72. AmpliPhi Biosciences Business Overview
Table 73. AmpliPhi Biosciences Veterinary Vaccines Product
Table 74. AmpliPhi Biosciences Revenue in Veterinary Vaccines Business (2018-2023) & (US$ Million)
Table 75. AmpliPhi Biosciences Recent Development
Table 76. Aratana Therapeutics Company Detail
Table 77. Aratana Therapeutics Business Overview
Table 78. Aratana Therapeutics Veterinary Vaccines Product
Table 79. Aratana Therapeutics Revenue in Veterinary Vaccines Business (2018-2023) & (US$ Million)
Table 80. Aratana Therapeutics Recent Development
Table 81. ARKO Labs Company Detail
Table 82. ARKO Labs Business Overview
Table 83. ARKO Labs Veterinary Vaccines Product
Table 84. ARKO Labs Revenue in Veterinary Vaccines Business (2018-2023) & (US$ Million)
Table 85. ARKO Labs Recent Development
Table 86. Bayer Company Detail
Table 87. Bayer Business Overview
Table 88. Bayer Veterinary Vaccines Product
Table 89. Bayer Revenue in Veterinary Vaccines Business (2018-2023) & (US$ Million)
Table 90. Bayer Recent Development
Table 91. CanFel Therapeutics Company Detail
Table 92. CanFel Therapeutics Business Overview
Table 93. CanFel Therapeutics Veterinary Vaccines Product
Table 94. CanFel Therapeutics Revenue in Veterinary Vaccines Business (2018-2023) & (US$ Million)
Table 95. CanFel Therapeutics Recent Development
Table 96. Ceva Animal Health Company Detail
Table 97. Ceva Animal Health Business Overview
Table 98. Ceva Animal Health Veterinary VaccinesProduct
Table 99. Ceva Animal Health Revenue in Veterinary Vaccines Business (2018-2023) & (US$ Million)
Table 100. Ceva Animal Health Recent Development
Table 101. Colorado Serum Company Detail
Table 102. Colorado Serum Business Overview
Table 103. Colorado Serum Veterinary VaccinesProduct
Table 104. Colorado Serum Revenue in Veterinary Vaccines Business (2018-2023) & (US$ Million)
Table 105. Colorado Serum Recent Development
Table 106. Epitopix Company Detail
Table 107. Epitopix Business Overview
Table 108. Epitopix Veterinary VaccinesProduct
Table 109. Epitopix Revenue in Veterinary Vaccines Business (2018-2023) & (US$ Million)
Table 110. Epitopix Recent Development
Table 111. Genus Company Detail
Table 112. Genus Business Overview
Table 113. Genus Veterinary VaccinesProduct
Table 114. Genus Revenue in Veterinary Vaccines Business (2018-2023) & (US$ Million)
Table 115. Genus Recent Development
Table 116. Hygieia Biological Laboratories Company Detail
Table 117. Hygieia Biological Laboratories Business Overview
Table 118. Hygieia Biological Laboratories Veterinary VaccinesProduct
Table 119. Hygieia Biological Laboratories Revenue in Veterinary Vaccines Business (2018-2023) & (US$ Million)
Table 120. Hygieia Biological Laboratories Recent Development
Table 121. ImmuCell Company Detail
Table 122. ImmuCell Business Overview
Table 123. ImmuCell Veterinary VaccinesProduct
Table 124. ImmuCell Revenue in Veterinary Vaccines Business (2018-2023) & (US$ Million)
Table 125. ImmuCell Recent Development
Table 126. Nexvet Company Detail
Table 127. Nexvet Business Overview
Table 128. Nexvet Veterinary VaccinesProduct
Table 129. Nexvet Revenue in Veterinary Vaccines Business (2018-2023) & (US$ Million)
Table 130. Nexvet Recent Development
Table 131. Nuovo Biologics Company Detail
Table 132. Nuovo Biologics Business Overview
Table 133. Nuovo Biologics Veterinary VaccinesProduct
Table 134. Nuovo Biologics Revenue in Veterinary Vaccines Business (2018-2023) & (US$ Million)
Table 135. Nuovo Biologics Recent Development
Table 136. UBI Company Detail
Table 137. UBI Business Overview
Table 138. UBI Veterinary VaccinesProduct
Table 139. UBI Revenue in Veterinary Vaccines Business (2018-2023) & (US$ Million)
Table 140. UBI Recent Development
Table 141. Valneva Company Detail
Table 142. Valneva Business Overview
Table 143. Valneva Veterinary VaccinesProduct
Table 144. Valneva Revenue in Veterinary Vaccines Business (2018-2023) & (US$ Million)
Table 145. Valneva Recent Development
Table 146. Vetoquinol Company Detail
Table 147. Vetoquinol Business Overview
Table 148. Vetoquinol Veterinary VaccinesProduct
Table 149. Vetoquinol Revenue in Veterinary Vaccines Business (2018-2023) & (US$ Million)
Table 150. Vetoquinol Recent Development
Table 151. Virbac Company Detail
Table 152. Virbac Business Overview
Table 153. Virbac Veterinary VaccinesProduct
Table 154. Virbac Revenue in Veterinary Vaccines Business (2018-2023) & (US$ Million)
Table 155. Virbac Recent Development
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Veterinary Vaccines Market Share by Type: 2022 VS 2030
Figure 2. Inactivated Vaccines Features
Figure 3. Live Attenuated Vaccines Features
Figure 4. Conjugate Vaccines Features
Figure 5. Toxoid Vaccines Features
Figure 6. Recombinant Vaccines Features
Figure 7. DNA Vaccines Features
Figure 8. Others Features
Figure 9. Global Veterinary Vaccines Market Share by Application in 2022 & 2030
Figure 10. Veterinary Clinic Case Studies
Figure 11. Veterinary Hospital Case Studies
Figure 12. Veterinary Research Institute Case Studies
Figure 13. Retail Pharmacy Case Studies
Figure 14. Others Case Studies
Figure 15. Veterinary Vaccines Report Years Considered
Figure 16. Global Veterinary Vaccines Market Size (US$ Million), Year-over-Year: 2018-2030
Figure 17. Global Veterinary Vaccines Market Size, (US$ Million), 2018 VS 2022 VS 2030
Figure 18. Global Veterinary Vaccines Market Share by Region: 2022 VS 2030
Figure 19. Global Veterinary Vaccines Market Share by Players in 2022
Figure 20. Global Top Veterinary Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Vaccines as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by Veterinary Vaccines Revenue in 2022
Figure 22. North America Veterinary Vaccines Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 23. North America Veterinary Vaccines Market Share by Country (2018-2030)
Figure 24. United States Veterinary Vaccines Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 25. Canada Veterinary Vaccines Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 26. Europe Veterinary Vaccines Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 27. Europe Veterinary Vaccines Market Share by Country (2018-2030)
Figure 28. Germany Veterinary Vaccines Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 29. France Veterinary Vaccines Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 30. U.K. Veterinary Vaccines Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 31. Italy Veterinary Vaccines Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 32. Russia Veterinary Vaccines Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 33. Nordic Countries Veterinary Vaccines Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 34. Asia-Pacific Veterinary Vaccines Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 35. Asia-Pacific Veterinary Vaccines Market Share by Region (2018-2030)
Figure 36. China Veterinary Vaccines Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 37. Japan Veterinary Vaccines Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 38. South Korea Veterinary Vaccines Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 39. Southeast Asia Veterinary Vaccines Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 40. India Veterinary Vaccines Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 41. Australia Veterinary Vaccines Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 42. Latin America Veterinary Vaccines Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 43. Latin America Veterinary Vaccines Market Share by Country (2018-2030)
Figure 44. Mexico Veterinary Vaccines Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 45. Brazil Veterinary Vaccines Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 46. Middle East & Africa Veterinary Vaccines Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 47. Middle East & Africa Veterinary Vaccines Market Share by Country (2018-2030)
Figure 48. Turkey Veterinary Vaccines Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 49. Saudi Arabia Veterinary Vaccines Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 50. Elanco Revenue Growth Rate in Veterinary Vaccines Business (2018-2023)
Figure 51. Merck Revenue Growth Rate in Veterinary Vaccines Business (2018-2023)
Figure 52. Merial Revenue Growth Rate in Veterinary Vaccines Business (2018-2023)
Figure 53. Zoetis Revenue Growth Rate in Veterinary Vaccines Business (2018-2023)
Figure 54. Advaxis Revenue Growth Rate in Veterinary Vaccines Business (2018-2023)
Figure 55. AmpliPhi Biosciences Revenue Growth Rate in Veterinary Vaccines Business (2018-2023)
Figure 56. Aratana Therapeutics Revenue Growth Rate in Veterinary Vaccines Business (2018-2023)
Figure 57. ARKO Labs Revenue Growth Rate in Veterinary Vaccines Business (2018-2023)
Figure 58. Bayer Revenue Growth Rate in Veterinary Vaccines Business (2018-2023)
Figure 59. CanFel Therapeutics Revenue Growth Rate in Veterinary Vaccines Business (2018-2023)
Figure 60. Ceva Animal Health Revenue Growth Rate in Veterinary Vaccines Business (2018-2023)
Figure 61. Colorado Serum Revenue Growth Rate in Veterinary Vaccines Business (2018-2023)
Figure 62. Epitopix Revenue Growth Rate in Veterinary Vaccines Business (2018-2023)
Figure 63. Genus Revenue Growth Rate in Veterinary Vaccines Business (2018-2023)
Figure 64. Hygieia Biological Laboratories Revenue Growth Rate in Veterinary Vaccines Business (2018-2023)
Figure 65. ImmuCell Revenue Growth Rate in Veterinary Vaccines Business (2018-2023)
Figure 66. Nexvet Revenue Growth Rate in Veterinary Vaccines Business (2018-2023)
Figure 67. Nuovo Biologics Revenue Growth Rate in Veterinary Vaccines Business (2018-2023)
Figure 68. UBI Revenue Growth Rate in Veterinary Vaccines Business (2018-2023)
Figure 69. Valneva Revenue Growth Rate in Veterinary Vaccines Business (2018-2023)
Figure 70. Vetoquinol Revenue Growth Rate in Veterinary Vaccines Business (2018-2023)
Figure 71. Virbac Revenue Growth Rate in Veterinary Vaccines Business (2018-2023)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

DOWNLOAD SAMPLE

Download
Free Sample

Request
Customization

Check
Discount

Offer REPORT BUYING OPTIONS

Single User Price : $1611

Multi User Price : $2417

Enterprise Price : $3222

---- OR ----

Frequently Asked Questions ?

Delivery Time

Upto 24 hrs - Working days
Upto 48 hrs max - Weekends and public holidays

User License

Single User License
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

Multi user License
A license granted to multiple users.

Site License
A license granted to a single business site/establishment.

Corporate License, Global License
A license granted to all employees within organisation access to the product.

Payment Options

Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer

Report Delivery

Email
Hard Copy

Our Key Features

Data Accuracy and Reliability
Data Security
Customized Research
Trustworthy
Competitive Offerings

Global Veterinary Vaccines Market Research Report 2023

TABLE OF CONTENTS